Abstract. In this study, we examined the role of the bumetanide-sensitive Na+/K+/CI -cotransport in the mitogenic signal of human skin fibroblast proliferation . The Na+/K+/Cl -cotransport was dramatically stimulated by either fetal calf serum, or by recombinant growth factors, added to quiescent Go/Gt human skin fibroblasts . The following mitogens, FGF, PDGF, a-thrombin, insulin-like growth factor-1, transforming growth factor-a, and the phorbol ester, 12-0-tetradecanoyl-phorbol-13-acetate, all stimulated the Na+/K+/Cl -cotransport . In addition, all the above mitogens induced DNA synthesis in the synchronized human fibroblasts. In order to explore the role of the Na+/K+/Cl -cotransport in the mitogenic signal, the effect of two specific inhibitors of the cotransport, furosemide and bumetanide, was tested on cell proliferation induced by the above recombinant growth NE of the earliest responses of quiescent cells to a mitogenic signal is activation of Na+ influx (Rozengurt, 1986; Rozengurt and Mendoza, 1986) . The bumetanide-sensitive Na+/K+/Cl -cotransport was shown to be dramatically stimulated by the addition of serum growth factors to quiescent cells (Tupper et al., 1977; Pallet et al., 1982 Pallet et al., , 1983 Panet, 1985; Amsler et al., 1985; Paris and Pouyssegur, 1986; Panet et al., 1986a Panet et al., , 1989 . The question of whether the Na+/K+/Cl-cotransport has an essential role in the mitogenic response is still unsolved . Several groups have observed that inhibition of the Na+/K+/Cl-cotransport affected only slightly the initiation of DNA synthesis (Owen and Prastein, 1985 ; Amsler et al., 1985; Paris and Pouyssegur, 1986 ) . It has therefore been proposed that the Na+/K+/Cl-cotransport does not play a major role in the mitogenic signal (Amsler et al ., 1985 ; Paris and Pouyssegur, 1986) . Most ofthese studies, however, were carried out with immortal rodent cell lines. Nevertheless, the response of normal diploid human fibroblasts, rather than immortal cell lines to growth factors, may be different and more relevant to the normal control of cell proliferation . Recently, we have investigated the optimal conditions for thearrest ofhuman skin fibroblasts . Optimal cell density, du-0 The Rockefeller University Press, 0021-9525/91/07/337/6 $2 .00 The Journal of Cell Biology, Volume 114, Number 2, July 1991 337-342 factors. Bumetanide and furosemide inhibited synchronized cell proliferation as was measured by (a) cell exit from the Go/G, phase measured by the use of flow cytometry, (b) cell entering the S-phase, determined by DNA synthesis, and (c) cell growth, measured by counting the cells. The inhibition by furosemide and bumetanide was reversible, removal of these compounds, completely released the cells from the block of DNA synthesis . In addition, the two drugs inhibited DNA synthesis only when added within the first 2-6 h of cell release. These results indicate that the effect of these drugs is specific, and is not due to an indirect toxic effect . This study clearly demonstrates that the growth factor-induced activation of the Na+/K+/Cl-cotransport plays a major role in the mitogenic signaling pathway of the human fibroblasts . ration of serum deprivation, and the serum concentration in the arrest medium, were analyzed . We have shown that in cultures of human skin fibroblasts arrested under optimal conditions, the bumetanide-sensitive Na+/K+/Cl-cotransport is stimulated by two-to threefold after the addition of fetal calf serum, or purified recombinant growth factors (Panet and Allan, 1990) . In the present study, we analyzed, with the use of specific inhibitors furosemide and bumetanide, whether stimulation of the Na+/K+/Cl -cotransporter by serum growth factors is essential for human fibroblast proliferation . Our results indicate that the growth factorsinduced stimulation of the Na+/K+/Cl -cotransport is an essential part ofthe mitogenic signal of the human fibroblasts.
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Materials and Methods
[ 3H]Thymidine was purchased from the Nuclear Research Centre, BeerSheva, Israel . "Rb+ was purchased from NEN Research Products, Boston, MA . Bumetanide was kindly provided by Laboratoire Leo, B .P. 28500 Vernouillet, Denmark. Phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), ' propidium iodide, RNAase A, and ouabain were pur- 
Cell Cultures
Primary human skin fibroblasts were kindly provided by Dr. S. Yatziv, Department of Pediatrics, Hadassah University Hospital . Cells were grown in DMEM, supplemented with 10% fetal calf serum and 4 mM glutamine. This medium was replenished every 2 d. For the arrest of the cell in the Go/Gt-phase of the cell cycle, the cells were seeded in 10,000/15-mm dishes . After 2 d the cells were washed once, and the medium was replaced with DMEM, supplemented with 0.2 % FCS, 4 mM glutamine and 20 mM Hepes for two more days .
Rb+ Influx Measurements
Bumetanide-sensitive Rb+ influx was measured as reported (Panet et al ., 1982) . In brief, Rb+ influx in the presence of ouabain (0.5 mM) and bumetanide (10 AM) was subtracted from ouabain-resistant Rb+ influx, and taken as bumetanide-sensitive Rb+ influx, Each Rb+ influx measurement was conducted in triplicate cultures and the results (t SEM) were expressed for 1116 cells.
DNA Synthesis
Go/G, quiescent cells were released by the addition of FCS (10%) or the indicated mitogens, introduced directly into the arrest medium in the presence of [3 H]thymidine (0.5 ACi/ml). All thymidine incorporation measurements of this study were performed in the incubator, in the presence of CO2/HCO3 . Trichloroacetic acid-insoluble radioactivity was determined 48 h after the release.
Staining the DNA with Propidium Iodide for Flow Cytofluorometry Cells trypsinized and washed twice with cold PBS, were suspended in cold PBS (2 x 106 cells/ml), and fixed by adding slowly, under gentle stirring, 3 ml cold ethanol (95%). The suspension was kept in a refrigerator (4°C) for further analysis. Before analysis, the cell suspension was centrifuged (1,000 rpm, 5 min), the pellet was suspended in PBS (810 141) and RNase A (10 mg/ml, 90 Al) was added. After 30 min of incubation at 37°C, propidium iodide (0.5 mg/ml, 90 Al) was added. The samples were kept on ice until the analysis was conducted. Samples were run in the flow cytometer between 15 min and 3 h after the addition of propidium iodide . (Table I ) . The following mitogens : PDGF, bFGF, TPA (all at 1 ng/ml), TGFa, and IGF-1 (both at 100 ng/ml), all stimulated the bumetanide-sensitive Rb+ influx by about twofold of the control.
Effect of Bumetanide on DNA Synthesis Induced by a-'Thrombin in the Synchronized Human Fibroblasts
We next examined whether stimulation of the Na+/K+/Clcotransport is essential for the mitogenic signal . To this end, we measured the effect ofbumetanide, a specific inhibitor of the Na+/K+/Cl-cotransport, on synchronized cell entry into S-phase induced by a-thrombin . Human fibroblasts were arrested by serum deprivation, and a-thrombin was added in the presence of different bumetanide concentrations . The incorporation of [3H] thymidine into trichloroacetic acidinsoluble material was determined after 48 h release in the presence of C02/HCO3. As seen in Fig. 1 , bumetanide inhibited thymidine incorporation induced by of-thrombin . The effect ofbumetanide was dose dependent; at 100 AM concentration it inhibited a noteworthy fraction of thymidine incorporation into DNA (50%) induced by a-thrombin (Fig . 1 ) . However, the basal level of thymidine incorporation was not affected (Fig. 1 ) . Based on this result, bumetanide was added at 100 pM in all the experiments described in this study.
Effect of Bumetanide and Furosemide on Cell Growth and Exitfrom the Go/G,-Phase of the Cell Cycle
To analyze whether bumetanide does notjust inhibit the Synthesis of DNA, but in fact blocks cell proliferation, we measured cell replication by direct counting . Quiescent cells, which were starved for 48 h, were released by the addition of PDGF (10 ng/ml) or bFGF (1 ng/ml) in the absence or presence of bumetanide . Effect of bumetanide on cell proliferation induced by PDGF and FGF Quiescent human skin fibroblasts were released by the addition of PDGF (10 ng/ml) or FGF (1 ng/ml) in the absence or presence of bumetanide (100 AM) . After 3 d the cells were counted by Coulter counter.
Coulter counter. As seen in Fig . 2 , bumetanide (100 AM) added to synchronized human fibroblasts, inhibited cell growth induced by either PDGF or bFGF. Similar results were obtained with furosemide (data not shown) .
To directly determine the phase in which furosemide or bumetanide blocks cell cycle, the methodology of cytofluorometry was applied . As seen in Fig . 3 A, the synchronized control cells exit the G, and enter the S-phase at 16 h after serum addition . However, when serum was added in the presence of furosemide, cell exit from the G,-phase was much reduced (Fig. 3 B) . At 24 h after serum addition, 60% of the control cells exit the G,-phase, however, when cells are released in the presence of furosemide, only 27 % of the cells exit the G,-phase and enter the S-phase (Fig . 3 B) . Similar results were obtained with bumetanide (data not shown) .
Since three independent techniques suggested that bumetanide and f irosemide block cell cycle, we propose that the effect is mediated through inhibition of the Na+/K+/Clcotransport . . Effect offurosemide and bumetanide on thymidine incorporation induced by PDGF and bFGF Human skin fibroblasts were seeded and serum deprived for 2 d, as described in Materials and Methods . The indicated concentrations of PDGF or bFGF were added directly into the arrest medium with [3 H]thymidine (0.5 ACi/ml), in the absence or presence of furosemide (FA, 1 mM) or bumetanide (100 FiM) . After 48 h, trichloroacetic acid-insoluble radioactivity was determined and expressed as cpm/15-mm plate .
[3 H]Thymidine incorporation into DNA by the addition of FCS (10%) was 30,000 f 2,000 cpm/15-mm well.
PDGF and bFGF were found to be potent mitogens ofhuman skin fibroblasts (Fig . 4) . Both growth factors, PDGF (10 ng/ml) and bFGF (1 ng/ml) stimulated thymidine incorporation into DNA to a degree similar to that elicited by FCS (Fig. 6) . Bumetanide or furosemide inhibited a considerable fraction of the thymidine incorporation induced by either PDGF (40-54 %), or bFGF (46-78 %) . It appears that at high concentrations of bFGF the inhibition of DNA synthesis by bumetanide declined . This phenomenon could also be observed with PDGF but to a lesser extent (Fig. 4) . These two inhibitors may either be specific for inhibition of the stimulation of the Na+/K+/Cl -cotransport at the early Go/G,-phase, or they may exhibit an effect on cellular requirements for the Na+/K+/Cl -cotransport during the cell cycle . To resolve this question, we measured the effect of bumetanide when added to the synchronized cultures at different times after the release by PDGF As seen in 'Fable II addition of bumetanide within the first 2 h of cell release, inhibited thymidine incor-20 21.
Figure 3 Effect of furosemide on the cell cycle of synchronized cells induced by FCS . Human skin fibroblasts were seeded and serum deprived for 2 d, as described in Materials and Methods . The quiescent cells were released by the addition of FCS (5%) in the absence and presence of furosemide (1 mM), which was introduced 15 min before serum was added . At the indicated time cells were harvested, washed, fixed, and labeled with propidume iodide as described in Materials and Methods . Fluorescence distribution of the cells was measured using flow cytometer as described in Materials and Methods . In all samples 5,000 nuclei were analyzed by flow cytometry. potation into DNA by 45 %, however, when bumetanide was added 6-12 h after the addition ofPDGF, inhibition ofthymidine incorporation into DNA declined to 12% (')sable II) . This result supports the proposal that bumetanide specifically inhibits early events during cell exit from the Go/G, phase, rather than the cells' requirement for the Na+/K+/Clcotransport during the cell cycle.
Effect ofFurosemide on the Protein Kinase C-dependent Mitogenic Pathway
As seen in Table I , bumetanide-sensitive Rb+ influx is stimulated by the phorbol ester TPA . This result indicates the involvement of protein kinase C in the stimulation of the Na+/K+/Cl -cotransport in the human fibroblasts . To analyze whether stimulation of the Na+/K+/Cl-cotransport through the protein kinase C pathway (Nishizuka, 1984) plays a role in the mitogenic signal, we measured the consequences of inhibiting this transporter on DNA synthesis induced by TPA . The phorbol ester TPA is a relatively weak mitogen for human fibroblasts compared with FCS, PDGF, or bFGF Nevertheless, TPA at 0.1-10 ng/ml stimulated thymidine incorporation by 4.7-fold (Fig. 5 A) . Furosemide inhibited 40-50% of thymidine incorporation induced by TPA, and similar results were achieved by bumetanide (data not shown) . This observation suggests that stimulation ofthe Na+/K+/Cl-cotransport by protein kinase C-dependent pathway is involved in this mitogenic pathway.
Effect ofFurosemide on Protein Kinase C-independent Mitogenic Signal
EGF is mitogenic to human and mouse fibroblasts through a protein kinase C-independent pathway. In a recent paper we have demonstrated that the Na+/K+/Cl -cotransport is stimulated by both a protein kinase C-dependent mechanism and by the protein kinase C-independent pathway of the mitogenic signal (Panet and Adan, 1990) . To analyze whether stimulation of the Na+/K+/Cl -cotransport through the protein kinase C-independent pathways is also involved in the mitogenic signal, we measured the effect of furosemide on DNA synthesis induced by TGFa (Blackshear et al., 1985; Coughlin et al., 1985; Besterman et al ., 1986) . As seen in Fig . 5 B, TGFce is mitogenic to these cells, and
The furosemide at 1 mM inhibited a large portion (35-55%) of the mitogenic response to TGFa. This result suggests that stimulation of the Na+/K+/Cl -cotransport by the protein kinase C-independent pathway is also an essential part for this mitogenic pathway.
Bumetanide Inhibited DNA Synthesis Induced by FCS in the Human Fibroblasts
When the synchronized cells were released by FCS (10%), thymidine incorporation into DNA was inhibited by bumetanide to a smaller extent (in four independent experiments, 29 t 11% inhibition was obtained by bumetanide) than when the cells were released by the defined mitogens ( . Effect ofbumetanide and furosemide on thymidine incorporation induced by FCS. Human skin fibroblasts were seeded and serum deprived for 2 d, as described in Materials and Methods . The indicated concentrations of FCS were added directly into the arrest medium with [3 H]thymidine (0.5 ACi/ml) in the absence or presence of bumetanide (100 PM). After 48 h trichloroacetic acidinsoluble radioactivity was determined and expressed as cpm/15-mm plate. Thymidine incorporation into DNA at any designated FCS concentration, was taken as 100%, and the percentage of DNA synthesis in the presence of bumetanide was calculated and marked above the suitable bars .
Addition
Bumetanide addition time Figure 7 . Reversible inhibition of DNA synthesis by furosemide and bumetanide in synchronized human skin fibroblasts . Go/G,-phase-arrested human skin fibroblasts were released by the addition of PDGF (10 ng/ml), bFGF (1 ng/ml), or IGF-1 (100 ng/ml) in the absence (open bars) or presence (solid bars) of furosemide (FA, 1 mM) or bumetanide (bum ., 100 wM) with [3H]thymidine (0.5 jXi/ml) . After 48 h trichloroacetic acid-insoluble radioactivity was determined and expressed as cpm/15-mm plate. In parallel, other cultures were similarly released in the presence of the drugs for 48 h, then washed and fed with fresh medium containing the same mitogens without the drugs in the presence of ['H]thymidine (0.5 pCi/ml) . After a further 48-h trichloroacetic acid-insoluble radioactivity was determined and expressed as cpm/15-mm plate (crosshatched bars). Cultures that were exposed to furosemide or bumetanide in the absence of any drug in the first part of the experiment were released in the second step by the addition of FCS (10%) . Note that PDGF and FGF stimulated thymidine incorporation into DNA to a degree similar to that elicited by FCS.
bumetanide inhibition of thymidine incorporation is dependent on FCS concentrations. It appears'that at high concentrations of FCS, the inhibition of DNA synthesis by bumetanide declined . This phenomenon might indicate that high concentrations of FCS stimulate other transmembrane pathways which are not affected by bumetanide.
Reversible Inhibition ofCelt Proliferation by Furosemide and Bumetanide
To test whether inhibition of DNA synthesis by these compounds is due to a toxic effect, cell cultures which had been preincubated for 48 h with PDGF, bFGF, or IGF-1, in the presence of furosemide or bumetanide, were washed and fed with a fresh medium containing the same mitogens, but without the inhibitors . 48 h later we measured cell proliferation by thymidine incorporation into DNA . The inhibition by furosemide and bumetanide was reversible ; removal of these compounds completely released the cells from the block of DNA synthesis (Fig . 7) .
Discussion
The question of whether the Na+/K+/CI -cotransport plays a role in the mitogenic signal pathway is the subject of this study. We have demonstrated here, that the Na+/K+/Clcotransport is dramatically stimulated by either fetal calf serum, or by purified recombinant growth factors, added to quiescent Go/G, human skin fibroblasts. Furthermore, we have shown that two specific inhibitors of the Na+/K+/Clcotransport, furosemide and bumetanide, inhibited 50-80% of DNA synthesis induced by the various mitogens. Similarly, the two drugs inhibited cell growth and cell exit from the Go/G, phase of the cell cycle, induced by the growth factors . The following mitogens were found to stimulate the bumetanide-sensitive Na+/K+/Cl-cotransport in quiescent human fibroblasts : bFGF, PDGF, x--thrombin, IGF-1, TGF-«, and the phorbol ester TPA . To our knowledge, this is the first evidence that specific inhibitors of the Na+/K+/Clcotransport block cell proliferation . This study, therefore, indicates that the growth factor-induced activation of the Na+/K+/Cl-cotransport plays a major role in the mitogenic signal pathway. The finding that bumetanide inhibited DNA synthesis induced by both mitogens which stimulate protein kinase C (bFGF, PDGF, tx-thrombin ; Blackshear et al ., 1985 ; Coughlin et al ., 1985; Besterman et al ., 1986 ; L'AllePanet and Allan Buntetanide Inhibited Cell Growth in Human Fibroblasts main et al., 1986) and those which do not activate protein kinase C (TGFce and IGF-1 ; Blackshear et al ., 1985; Coughlin et al., 1985) , implies that stimulation of the Na+/K+ICl-cotransport has an essential role in the two mitogenic pathways . The degree of cell-cycle inhibition by bumetanide and furosemide depends on the concentration of the specific mitogen . This is most distinct with bFGF and FCS (see Figs . 4 and 6) . It seems quite clear that increasing the mitogen concentrations, overcomes the inhibition by bumetanide or furosemide. This phenomenon is especially dominated in cells induced by FCS . This might indicate that high concentrations of the mitogen induce other transport systems which replace the Na+/K+/Cl-cotransport .
The following evidence indicates that the two drugs block cell exit from the Go/G,-phase of the cell cycle by inhibiting the Na+/K+/Cl-cotransport . (a) Bumetanide and furosemide inhibited thymidine incorporation into DNA only when added within the first 2-6 h of cell release . (b) In correlation to its effect on thymidine incorporation, the two drugs inhibited also cell growth (Fig . 2) and cell exit from the Go/G,-phase, as measured by flow cytometry (Fig. 3) . (c) The two drugs reversibly inhibited thymidine incorporation into DNA induced by different mitogens (Figs . I and 4-7) .
The finding that bumetanide and furosemide inhibited similarly cell proliferation, cell exit from the Go/G,-phase and thymidine incorporation, excludes the possibility that the two drugs repress thymidine uptake, rather than thymidine incorporation into DNA . In addition, it also excludes the contingency that it slows down DNA synthesis rather than blocking it. Inhibition of cell proliferation by the two drugs might exhibit cell requirement for the Na+/K+/Cl -cotransport during the cell cycle, rather than specific inhibition of the cotransport stimulation by the mitogens . The finding that bumetanide inhibited thymidine incorporation within the first hours of PDGF addition, whereas 8-12 h after the mitogenic stimulation, the inhibition declined, implies thatthis inhibitor is specific for a direct mitogen response. The finding that bumetanide only slightly inhibited (12 % inhibition) thymidine incorporation when added 12 hafter PDGF addition, together with the finding that the inhibition is reversible, excludes the possibility that it has a toxic rather than specific effect.
The bumetanide-sensitive Na+/K+/Cl -cotransport was reported to be dramatically stimulated by serum growth factors in immortal cell lines such as 3T3 mouse cells, or in hamster fibroblasts (Tupper et al ., 1977; Panet et al ., 1982 Panet et al ., , 1983 Panet, 1985 ; Amsler et al ., 1985; Paris and Pouys-34 1 segur,1986 ; Panet et al., 1986a Panet et al., ,b, 1989 . On the other hand, one report has suggested that this transporter is only slightly stimulated in human diploid fibroblasts (Owen and Prastein, 1985) . Recently we have established optimal conditions for arresting human skin fibroblasts at the Go/G,-phase of the cell cycle (Panet and Atlan, 1990) . Under these conditions, the Na+/K+/Cl-cotransport is two-to threefold stimulated by either fetal calfserum or purified recombinant growth factors. The observation that this transporter in human fibroblasts was only slightly stimulated by growth factors (Owen and Prastein, 1985) could be due to the insufficient period of serum starvation (4 h).
In summary, we have shown that bumetanide or furosemide, added to quiescent human skin fibroblasts, inhibited 50-80% of cell proliferation induced by different mitogens. This study demonstrates that the growth factor stimulation of the Na+/K+/Cl-cotransport plays an essential role in the mitogenic signal of the human fibroblasts .
